Newsroom - Page 2

Prescription drug spending didn't rise as much as it did in 2014, but it still outpaced all other categories.
Researchers considered finding a diabetes drug that also produced a cardiovascular benefit to be a "holy grail."
The phenomenon of "yo-yo" dieting has health consequences and frustrates dieters themselves. Studies show each round of weight loss and weight regain produces harsher metabolic effects.
NICE recommends pembrolizumab for use in advanced lung cancer following additional data review and a further discount in price.
What we’re reading, December 2, 2016: Johnson & Johnson must pay $1 billion to patients injured by Pinnacle hip implants; 3 organizations join forces on initiative to prevent suicides in physicians and medical trainees; the American Hospital Association has sent a letter to President-elect Donald Trump with a list of requests for his administration.
Research from the Dana-Farber Cancer Institute and the Broad Institute, published in Nature, has identified genomic changes that could explain the development of testicular cancer and why this disease is more responsive to chemotherapy.
In a show of bipartisanship, the House of Representatives overwhelmingly passed the 21st Century Cures Act on November 30 by a vote of 392-26. Here are 5 things to know about the legislation.
A review of our peer-reviewed research in the healthcare and mainstream press.
Diabetes Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium